glp-1 obesity drug news october 21 2025 Use of diabetes and anti-obesity drugs surges nationwide Weighty issue: GLP-1 drugs are

FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder

According to the company, at Week 48, among participants receiving the 24 mg dose of CT-388, 95.7% lost at least 5% of their body weight, 87% lost at least 10%, 47.8% lost at least 20%, and 26.1% lost at least 30%

These germ-free mice have no gut bacteria and so cannot make TMAO no matter how much choline or L-carnitine they were fed

L-carnitine HT est une carnitine premium certifie Carnipure : une formule brevete de haute qualit, ni thermognique ni stimulante, et peut donc tre utilise par les personnes sensibles la cafine

We also observed an age difference in serum homocysteine levels of the children with ASD

All information on this page is provided only for laboratory research context